The concomitant utilization of oxycodone HCl with all cytochrome P450 3A4 inhibitors may well cause an increase in oxycodone plasma concentrations, which could raise or lengthen adverse reactions and may lead to possibly deadly respiratory despair. In addition, discontinuation of a concomitantly app